NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation

Li Qian, Xi Gao, Zhong Pei, Xuefei Wu, Michelle Block, Belinda Wilson, Jau Shyong Hong, Patrick M. Flood

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

In this paper we report that diphenyliodonium (DPI), a NADPH oxidase inhibitor, shows potent anti-inflammatory and neuroprotective effects at femtomolar concentrations (10-13 to 10-14 M) in primary midbrain cultures. Mechanistic studies revealed that DPI-elicited effects were mediated by the inhibition of LPS-induced microglial ROS production and the subsequent release of pro-inflammatory cytokine TNFa, and the production of nitric oxide. Further studies showed that 10-14 M DPI significantly reduced LPS-induced ERK phosphorylation. Taken together, our results demonstrate that femtomolar concentrations of DPI exert potent anti-inflammatory and neuroprotective effects by inhibiting microglial activation through the inhibition of ERK-regulated PHOX activity.

Original languageEnglish (US)
Pages (from-to)S316-S320
JournalParkinsonism and Related Disorders
Volume13
Issue numberSUPPL. 3
DOIs
StatePublished - Dec 1 2007

Fingerprint

NADPH Oxidase
Microglia
Neuroprotective Agents
Anti-Inflammatory Agents
Mesencephalon
Nitric Oxide
Phosphorylation
Cytokines
diphenyliodonium

Keywords

  • Femtomolar DPI
  • Inflammation
  • LPS
  • Microglia
  • ROS

ASJC Scopus subject areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Cite this

NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation. / Qian, Li; Gao, Xi; Pei, Zhong; Wu, Xuefei; Block, Michelle; Wilson, Belinda; Hong, Jau Shyong; Flood, Patrick M.

In: Parkinsonism and Related Disorders, Vol. 13, No. SUPPL. 3, 01.12.2007, p. S316-S320.

Research output: Contribution to journalArticle

Qian, Li ; Gao, Xi ; Pei, Zhong ; Wu, Xuefei ; Block, Michelle ; Wilson, Belinda ; Hong, Jau Shyong ; Flood, Patrick M. / NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation. In: Parkinsonism and Related Disorders. 2007 ; Vol. 13, No. SUPPL. 3. pp. S316-S320.
@article{fa03aebbfcf2419d9e98f28796da7506,
title = "NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation",
abstract = "In this paper we report that diphenyliodonium (DPI), a NADPH oxidase inhibitor, shows potent anti-inflammatory and neuroprotective effects at femtomolar concentrations (10-13 to 10-14 M) in primary midbrain cultures. Mechanistic studies revealed that DPI-elicited effects were mediated by the inhibition of LPS-induced microglial ROS production and the subsequent release of pro-inflammatory cytokine TNFa, and the production of nitric oxide. Further studies showed that 10-14 M DPI significantly reduced LPS-induced ERK phosphorylation. Taken together, our results demonstrate that femtomolar concentrations of DPI exert potent anti-inflammatory and neuroprotective effects by inhibiting microglial activation through the inhibition of ERK-regulated PHOX activity.",
keywords = "Femtomolar DPI, Inflammation, LPS, Microglia, ROS",
author = "Li Qian and Xi Gao and Zhong Pei and Xuefei Wu and Michelle Block and Belinda Wilson and Hong, {Jau Shyong} and Flood, {Patrick M.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1016/S1353-8020(08)70023-3",
language = "English (US)",
volume = "13",
pages = "S316--S320",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "SUPPL. 3",

}

TY - JOUR

T1 - NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation

AU - Qian, Li

AU - Gao, Xi

AU - Pei, Zhong

AU - Wu, Xuefei

AU - Block, Michelle

AU - Wilson, Belinda

AU - Hong, Jau Shyong

AU - Flood, Patrick M.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - In this paper we report that diphenyliodonium (DPI), a NADPH oxidase inhibitor, shows potent anti-inflammatory and neuroprotective effects at femtomolar concentrations (10-13 to 10-14 M) in primary midbrain cultures. Mechanistic studies revealed that DPI-elicited effects were mediated by the inhibition of LPS-induced microglial ROS production and the subsequent release of pro-inflammatory cytokine TNFa, and the production of nitric oxide. Further studies showed that 10-14 M DPI significantly reduced LPS-induced ERK phosphorylation. Taken together, our results demonstrate that femtomolar concentrations of DPI exert potent anti-inflammatory and neuroprotective effects by inhibiting microglial activation through the inhibition of ERK-regulated PHOX activity.

AB - In this paper we report that diphenyliodonium (DPI), a NADPH oxidase inhibitor, shows potent anti-inflammatory and neuroprotective effects at femtomolar concentrations (10-13 to 10-14 M) in primary midbrain cultures. Mechanistic studies revealed that DPI-elicited effects were mediated by the inhibition of LPS-induced microglial ROS production and the subsequent release of pro-inflammatory cytokine TNFa, and the production of nitric oxide. Further studies showed that 10-14 M DPI significantly reduced LPS-induced ERK phosphorylation. Taken together, our results demonstrate that femtomolar concentrations of DPI exert potent anti-inflammatory and neuroprotective effects by inhibiting microglial activation through the inhibition of ERK-regulated PHOX activity.

KW - Femtomolar DPI

KW - Inflammation

KW - LPS

KW - Microglia

KW - ROS

UR - http://www.scopus.com/inward/record.url?scp=38949146389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949146389&partnerID=8YFLogxK

U2 - 10.1016/S1353-8020(08)70023-3

DO - 10.1016/S1353-8020(08)70023-3

M3 - Article

C2 - 18267257

AN - SCOPUS:38949146389

VL - 13

SP - S316-S320

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - SUPPL. 3

ER -